Results 201 to 210 of about 42,925 (253)

The role of circulating cytokines in eosinophilic esophagitis: A Mendelian randomization and gene expression analysis study. [PDF]

Medicine (Baltimore)
Jiang L, Xue T, Zheng L, Zhang X, Qu X, Zhang Q.   +5 more
europepmc   +1 more source

Disease Progression Mathematical Modeling With a Case Study on Hepatitis B Virus Infection

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 420-434, March 2025.
ABSTRACT Chronic Hepatitis B presents a significant health and socioeconomic burden. The risk of hepatocellular carcinoma remains elevated although treatments are available. Achieving an optimal treatment regimen necessitates a deep comprehension of the dynamic relationship between the virus and its host across disease states.
Clémence Boivin‐Champeaux, Nieves Velez de Mendizabal, Aksana Jones, Scott Balsitis, Stephan Schmidt, Justin S. Feigelman, Francine Johansson Azeredo   +6 more
wiley   +1 more source

Periodontitis and Chronic Liver Disease: Mechanistic Insights Focusing on <i>Porphyromonas gingivalis</i>-A Narrative Review. [PDF]

Microorganisms
Ying Y, Nie Y, Zhao J, Dong Q, Chen M, Jiang A, Liu N, Xu T, Liu J, Pan Y, Lin L, Zhang D.   +11 more
europepmc   +1 more source

A 3D bioengineered human liver for the study of acute and chronic drug-induced hepatotoxicity and fibrosis. [PDF]

Front Bioeng Biotechnol
Ferret-Miñana A, Alcaraz E, Horrillo R, Ramón-Azcón J, De Chiara F.   +4 more
europepmc   +1 more source

Hepatocellular carcinoma in a child with hereditary tyrosinemia type I despite early NTBC therapy: When should we suspect it? [PDF]

Radiol Case Rep
Ouassou KL, Abilkassem R.
europepmc   +1 more source

Coagulation protease-activated receptor-2 (PAR2) promotes dyslipidemia, obesity and MASLD through repression of the hepatic pioneer factor HNF4α. [PDF]

JHEP Rep
Chen X, Nguyen N, Turner SE, Tai AK, Abdelmalek MF, Covic L, Kuliopulos A.   +6 more
europepmc   +1 more source

F13A1-Mediated Macrophage Activation Promotes MASH Progression via the PKM2/HIF1A Pathway. [PDF]

Adv Sci (Weinh)
Lu Q, Ong M, Yi X, Xing M, Tian X, Zhang K, Lu L, Wang H, Lin X, Fang J, Mu A, Cao J, Jiang J, Gao F, Li H, Wang B, Ling Q.   +16 more
europepmc   +1 more source

Experimental Models of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comparative Analysis of a Choline-Deficient and Cholesterol-Enriched Diet in Rats. [PDF]

Int J Mol Sci
Shipelin VA, Petrov NA, Trusov NV, Sidorova YS, Markova YM, Chalyy ZA, Konev AD, Balakina AS.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hepatocyte nuclear factor 1 alpha (HNF-1?) mutations in maturity-onset diabetes of the young

Human Mutation, 2000
Maturity-onset diabetes of the young (MODY) is a monogenic form of diabetes mellitus characterized by autosomal dominant inheritance, early age of onset (
Siân Ellard, S Ellard
exaly   +3 more sources